Sec Form 3 Filing - Groupe Bruxelles Lambert @ Concentrix Corp - 2023-09-25

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Groupe Bruxelles Lambert 2. Issuer Name and Ticker or Trading Symbol Concentrix Corp [ CNXC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O GROUPE BRUXELLES LAMBERT, 24 AVENUE MARNIX 3. Date of Earliest Transaction (MM/DD/YY) 09/25/2023 (Street) BRUSSELLS, C91000 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 8,773,667 ( 1 ) I See Footnotes ( 2 ) ( 3 ) ( 4 ) ( 5 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Contingent Right to Common Stock ( 6 ) ( 6 ) ( 6 ) Common Stock 442,759 I See Footnote ( 6 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Groupe Bruxelles Lambert C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX BRUSSELLS, C91000 X FINPAR VI SA C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX BRUSSELLS, C91000 X FINPAR V SA C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX BRUSSELLS, C91000 X Sapiens S.a r.l. C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX BRUSSELLS, C91000 X GBL Verwaltung S.A. C/O GROUPE BRUXELLES LAMBERT 24 AVENUE MARNIX BRUSSELLS, C91000 X Signatures FINPAR VI SA, By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director 10/05/2023 Signature of Reporting Person Date FINPAR VI SA, By: /s/ Xavier Likin, Name: Xavier Likin, Title: Director 10/05/2023 Signature of Reporting Person Date FINPAR V SA, By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director 10/05/2023 Signature of Reporting Person Date FINPAR V SA, By: /s/ Xavier Likin, Name: Xavier Likin, Title: Director 10/05/2023 Signature of Reporting Person Date Sapiens S.ar.l., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director 10/05/2023 Signature of Reporting Person Date Sapiens S.ar.l., By: /s/ Serge Saussoy, Name: Serge Saussoy, Title: Director 10/05/2023 Signature of Reporting Person Date GBL Verwaltung S.A., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: Director 10/05/2023 Signature of Reporting Person Date GBL Verwaltung S.A., By: /s/ Serge Saussoy, Name: Serge Saussoy, Title: Director 10/05/2023 Signature of Reporting Person Date Groupe Bruxelles Lambert., By: /s/ Priscilla Maters, Name: Priscilla Maters, Title: General Counsel 10/05/2023 Signature of Reporting Person Date Groupe Bruxelles Lambert., By: /s/ Xavier Likin, Name: Xavier Likin, Title: Chief Financial Officer 10/05/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Reflects shares of Common Stock, par value $0.0001 per share ("Common Stock"), of Concentrix Corporation (the "Issuer") that were issued in connection with the consummation of transactions contemplated by the Share Purchase and Contribution Agreement (the "SPA"), dated as of June 12, 2023, by and among the Issuer and OSYRIS S.A R.L., MARNIX LUX SA, the Sellers named therein and the Seller Representatives. ( 2 )38,623 shares are held directly by FINPAR VI SA, 35,964 shares are held directly by FINPAR V SA and 8,699,080 shares are held directly by Sapiens S.ar.l. (the "Direct Holders"). ( 3 )GBL Verwaltung S.A. is the parent company of Sapiens S.a r.l. Groupe Bruxelles Lambert is the parent company of GBL Verwaltung S.A., Sapiens S.a r.l, FINPAR VI SA and of FINPAR V SA. ( 4 )Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. ( 5 )Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. ( 6 )Pursuant to, and subject to the terms and conditions in, the SPA, the Direct Holders have the contingent right to receive up to 442,759 shares of Common Stock if the share price of the Common Stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00. FINPAR VI SA has the contingent right to receive up to 1,949 shares of Common Stock. FINPAR V SA has the contingent right to receive up to 1,814 shares of Common Stock. Sapiens S.ar.l. has the contingent right to receive up to 438,996 shares of Common Stock.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.